About Clavix

What is Clavix?

Clavix is an iPhone app that grades the risk of US stocks and ETFs on a familiar A+ to F report-card scale and writes you a plain-English risk brief before market open. It scores 1,017 US stocks and ETFs every trading day across five independent risk dimensions, so you can see if anything you hold got more dangerous overnight without reading a single earnings call.

What Clavix does

What Clavix does not do

Who Clavix is for

Individual, self-directed investors who hold their own US stocks and ETFs and want a fast, honest read on risk. It suits people who check their holdings in the morning, want to understand risk without a finance background, and prefer not to link a brokerage account to a third-party app. It is built for retail investors, not institutions or advisers.

Coverage and how it works

Clavix currently covers 1,017 US stocks and ETFs. Every night it scores the universe, rolls the four weighted dimensions into one composite letter grade per name, and generates each subscriber's brief before the market opens. The fifth dimension, financial health, is scored and shown next to the grade and is not weighted into it. You can preview the same real grades on the web in the stock risk directory, or read the full grading methodology.

Pricing

Clavix Pro is free for three months, then $19.99 per month or $149.99 per year, billed through your Apple ID. Everything is included from the first day. It auto-renews until you cancel, and you can cancel anytime in your App Store settings.

Who is behind Clavix

Clavix is built and operated by Andover Digital LLC, a US company. Support is handled directly by the team at [email protected], usually within one business day.

Get Clavix on iPhone →